Search - tctmd.com

Displaying 21 - 40 of 946

Sort: Relevancy | Date

Presentation TCT 2016

PARTNER I FIVE-YEAR ECHO: Long-term Hemodynamic and Structural Outcomes After Transcatheter Aortic Valve Replacement in High-Risk and Inoperable Patients With Aortic Stenosis

Presenter: Gregg W. Stone, Philippe Pibarot, Pamela S. Douglas

November 01, 2016

News Industry News TCT 2016

Patients With Sever Aortic Stenosis And Intermediate Surgical Risk Show Similar Late Quality of Life Outcomes Following Either Transcatheter or Surgical Aortic Valve Replacement

November 01, 2016

Presentation TCT 2016

PARTNER II QUALITY OF LIFE: Health Status Benefits From a Prospective, Randomized Trial of Transcatheter and Surgical Aortic Valve Replacement in Intermediate-Risk Patients With Severe Aortic Stenosis

Presenter: Gregg W. Stone, Philippe Pibarot, David J. Cohen

November 01, 2016

Presentation TCT 2016

SENTINEL: A Prospective, Randomized Trial Evaluating Cerebral Protection in Patients With Severe Aortic Stenosis Undergoing Transcatheter Aortic Valve Replacement

Presenter: Gregg W. Stone, Philippe Pibarot, Susheel K. Kodali

November 01, 2016

Presentation TCT 2016

TCT 1524: Simultaneous Transfemoral Aortic and Transseptal Mitral Valves Replacement Utilizing Sapien 3 Valves in Native Aortic and Mitral Valves

Presenter: David R. Holmes Jr., Clifford J. Kavinsky, Firas Zahr

October 31, 2016

Presentation TCT 2016

TCT 1497:First Case of Transcatheter Aortic and Mitral Valve Replacements

Presenter: Jean-Claude Laborde, Thomas Walther, Hellmuth Weich

October 31, 2016

Presentation TCT 2016

Surgical and Transcatheter Aortic Valve Replacement for Patients With Heart Failure and High and Low Gradient Aortic Stenosis: Magnitude of Benefit and Prediction of Responders

Presenter: Jeroen J. Bax, Ileana L. Pina, Ori Ben-Yehuda

October 31, 2016

TCT 80: Transradial Diagnostic and Therapeutic Coronary Catheterization for Patients With NSTEMI or UAP Using One 4.0-Fr Sheath and One Sheathless Eaucathe Guide Catheter via One Puncture Site: 1-1-1 Trial

Presentation TCT 2016

TCT 80: Characterizing the Incidence and Predictors of Paravalvular Regurgitation after Transcatheter Aortic Valve Replacement (TAVR) and its Impact on Outcomes: A Study of the Society of Thoracic Surgeons/American College of Cardiology Transcatheter Valv

Presenter: John M. Lasala, Philippe Pibarot, Saif Anwaruddin

October 31, 2016

Presentation TCT 2016

TCT 83: Transcatheter Aortic Valve Replacement With Different Valve Designs for Elliptic Aortic Annulus Shape

Presenter: Mayra Guerrero, Roger J. Laham, Yoshio Maeno

October 31, 2016

Presentation TCT 2016

TCT 79: Course of Early Subclinical Leaflet Thrombosis After Transcatheter Aortic Valve Replacement With or Without Oral Anticoagulation

Presenter: John M. Lasala, Philippe Pibarot, Jürgen Rothe

October 31, 2016

Presentation TCT 2016

TCT 82: Evaluation of Current Practices in Transcatheter Aortic Valve Replacement: The WRITTEN (Worldwide TAVR Experience)Survey

Presenter: Mayra Guerrero, Roger J. Laham, Luis Nombela-Franco

October 31, 2016

Presentation TCT 2016

TCT 81: Clinical and Hemodynamic Results After Direct Transcatheter Aortic Valve Replacement Versus Pre-Implantation Balloon Aortic Valvuloplasty. A Case-Matched Analysis

Presenter: Mayra Guerrero, Roger J. Laham, Luis Nombela-Franco

October 31, 2016

Presentation TCT 2016

TCT 77: Association of Residual Mitral Regurgitation After Transcatheter Aortic Valve Replacement With Readmission for Acute Heart Failure: An Analysis From PARTNER 1

Presenter: John M. Lasala, Philippe Pibarot, John Petersen

October 31, 2016

Presentation TCT 2016

TCT 36: Frailty in Intermediate Risk Patients Undergoing Transcatheter or Surgical Aortic Valve Replacement, Cut Points and Relationship With Outcomes: An Analysis of the Placement of Aortic Transcatheter Valves (PARTNER) 2 Cohort A Randomized Trial

Presenter: Charles J. Davidson, Michael J. Reardon, Philip Green

October 31, 2016

Presentation TCT 2016

A Multicenter, Prospective Registry of Transcaval access and closure for transcatheter aortic valve replacement

Presenter: Joseph A. Hill, Steven P. Marso, Adam B. Greenbaum

October 31, 2016

Presentation TCT 2016

TCT 39: Three-Year Outcomes With the Fully Repositionable and Retrievable Lotus Transcatheter Aortic Replacement Valve in 120 High-Risk Surgical Patients With Severe Aortic Stenosis: Results From the REPRISE II CE-Mark Study

Presenter: Lutz Buellesfeld, Raj Makkar, Ian T. Meredith

October 31, 2016

Presentation TCT 2016

TCT 35: Predictors of Early Aortic Valve Rehospitalization Following Self-Expanding Transcatheter Aortic Valve Replacement: Results From the CoreValve US Trial Program

Presenter: Charles J. Davidson, Michael J. Reardon, James B. Hermiller Jr.

October 31, 2016

Presentation TCT 2016

TCT 38: Paravalvular Regurgitation Regression and Impact on One-Year Outcomes After Transcatheter Aortic Valve Replacement With the SAPIEN 3 Transcatheter Valve

Presenter: Lutz Buellesfeld, Raj Makkar, Philippe Pibarot

October 31, 2016

Presentation TCT 2016

TCT 37: Transcatheter Aortic Valve Replacement With a Repositionable Self-Expanding Bioprosthesis in Patients With Severe Aortic Stenosis at High Risk for Surgery: One-Year Results From the Evolut R US Pivotal Study

Presenter: Lutz Buellesfeld, Raj Makkar, Jeffrey J. Popma

October 31, 2016

Presentation TCT 2016

TCT 33: Predictors of Hospital Readmissions After Transcatheter Aortic Valve Replacement

Presenter: Charles J. Davidson, Michael J. Reardon, James Harvey

October 31, 2016

Advertisement

PARTNER I FIVE-YEAR ECHO: Long-term Hemodynamic and Structural Outcomes After Transcatheter Aortic Valve Replacement in High-Risk and Inoperable Patients With Aortic Stenosis

Patients With Sever Aortic Stenosis And Intermediate Surgical Risk Show Similar Late Quality of Life Outcomes Following Either Transcatheter or Surgical Aortic Valve Replacement

PARTNER II QUALITY OF LIFE: Health Status Benefits From a Prospective, Randomized Trial of Transcatheter and Surgical Aortic Valve Replacement in Intermediate-Risk Patients With Severe Aortic Stenosis

SENTINEL: A Prospective, Randomized Trial Evaluating Cerebral Protection in Patients With Severe Aortic Stenosis Undergoing Transcatheter Aortic Valve Replacement

TCT 1524: Simultaneous Transfemoral Aortic and Transseptal Mitral Valves Replacement Utilizing Sapien 3 Valves in Native Aortic and Mitral Valves

TCT 1497:First Case of Transcatheter Aortic and Mitral Valve Replacements

Surgical and Transcatheter Aortic Valve Replacement for Patients With Heart Failure and High and Low Gradient Aortic Stenosis: Magnitude of Benefit and Prediction of Responders

TCT 80: Characterizing the Incidence and Predictors of Paravalvular Regurgitation after Transcatheter Aortic Valve Replacement (TAVR) and its Impact on Outcomes: A Study of the Society of Thoracic Surgeons/American College of Cardiology Transcatheter Valv

TCT 83: Transcatheter Aortic Valve Replacement With Different Valve Designs for Elliptic Aortic Annulus Shape

TCT 79: Course of Early Subclinical Leaflet Thrombosis After Transcatheter Aortic Valve Replacement With or Without Oral Anticoagulation

TCT 82: Evaluation of Current Practices in Transcatheter Aortic Valve Replacement: The WRITTEN (Worldwide TAVR Experience)Survey

TCT 81: Clinical and Hemodynamic Results After Direct Transcatheter Aortic Valve Replacement Versus Pre-Implantation Balloon Aortic Valvuloplasty. A Case-Matched Analysis

TCT 77: Association of Residual Mitral Regurgitation After Transcatheter Aortic Valve Replacement With Readmission for Acute Heart Failure: An Analysis From PARTNER 1

TCT 36: Frailty in Intermediate Risk Patients Undergoing Transcatheter or Surgical Aortic Valve Replacement, Cut Points and Relationship With Outcomes: An Analysis of the Placement of Aortic Transcatheter Valves (PARTNER) 2 Cohort A Randomized Trial

A Multicenter, Prospective Registry of Transcaval access and closure for transcatheter aortic valve replacement

TCT 39: Three-Year Outcomes With the Fully Repositionable and Retrievable Lotus Transcatheter Aortic Replacement Valve in 120 High-Risk Surgical Patients With Severe Aortic Stenosis: Results From the REPRISE II CE-Mark Study

TCT 35: Predictors of Early Aortic Valve Rehospitalization Following Self-Expanding Transcatheter Aortic Valve Replacement: Results From the CoreValve US Trial Program

TCT 38: Paravalvular Regurgitation Regression and Impact on One-Year Outcomes After Transcatheter Aortic Valve Replacement With the SAPIEN 3 Transcatheter Valve

TCT 37: Transcatheter Aortic Valve Replacement With a Repositionable Self-Expanding Bioprosthesis in Patients With Severe Aortic Stenosis at High Risk for Surgery: One-Year Results From the Evolut R US Pivotal Study

TCT 33: Predictors of Hospital Readmissions After Transcatheter Aortic Valve Replacement

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content